MRK

Merck News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Pro
Monthly Subscription
for only
$49.05
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Merck and Co Inc MRK NYSE Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.04 0.05% 76.73 76.40 77.35 76.75 76.69 20:00:00
more quote information »

Recent News

Date Time Source Heading
7/09/202017:40DJNMerck Animal Health Gets FDA Approval of Bravecto Monthly..
7/09/202016:30BWMerck Animal Health Receives U.S. FDA Approval of BRAVECTO®..
7/09/202007:29DJNMerck Gets FDA Priority Review of Keytruda in Classical..
7/09/202006:45BWFDA Grants Priority Review to Merck’s Supplemental Biologics..
7/08/202016:30BWMerck Announces Appointment of Organon & Co. General Counsel
7/08/202007:59DJNAstraZeneca, Merck Get Europe OK for Lynparza in Pancreatic..
7/08/202006:55BWLYNPARZA® (olaparib) Approved in the EU for Germline..
7/08/202006:45BWMerck & Eisai Receive Complete Response Letter for KEYTRUDA®..
7/06/202006:45BWMerck Announces New Analyses Showing Additional Safety &..
7/02/202015:45EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202014:46EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202014:46EDGARStatement of Changes in Beneficial Ownership (4)
7/02/202002:00BWMerck Animal Health Completes Acquisition of U.S. Rights to..
7/01/202016:30BWMerck and Ridgeback Bio Announce Closing of Collaboration..
7/01/202006:45BWMerck to Hold Second-Quarter 2020 Sales and Earnings..
6/29/202016:20BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) for..
6/24/202017:29BWFDA Approves Merck’s KEYTRUDA® (pembrolizumab) for the..
6/24/202016:21EDGARCurrent Report Filing (8-k)
6/24/202006:45BWMerck Underscores Commitment to HIV with New Data Analyses..
6/23/202014:18EDGARAnnual Report of Employee Stock Plans (11-k)
6/22/202006:45BWMerck Announces That V114, Its Investigational 15-valent..
6/22/202006:30BWMerck’s KEYTRUDA® (pembrolizumab) Approved in China for..
6/19/202008:29BWMerck Completes Acquisition of Themis
6/18/202017:00EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/17/202016:30BWMerck Animal Health Completes Acquisition of Quantified Ag®
6/17/202006:45BWFDA Approves Second Biomarker-Based Indication for Merck’s..
6/17/202006:30BWMerck Prices $4.5 Billion Debt Offering
6/16/202013:15BWMerck & Pfizer’s SGLT2 Inhibitor STEGLATROTM (ertugliflozin)..
6/16/202009:05EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
6/15/202008:00BWMerck Announces Call for Proposals for Second Cohort of..
6/12/202018:40BWFDA Approves Merck’s GARDASIL 9 for the Prevention of..
6/09/202016:05BWMerck Provides Update on Phase 3 KEYNOTE-361 Trial..
6/05/202006:50BWFDA Approves Merck’s RECARBRIO™ (imipenem, cilastatin, &..
6/02/202017:44EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:17EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:16EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:15EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:14EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:13EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:12EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:11EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:08EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:08EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:03EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:02EDGARStatement of Changes in Beneficial Ownership (4)
6/02/202017:01EDGARInitial Statement of Beneficial Ownership (3)
6/01/202006:45BWLYNPARZA® (olaparib) Receives Positive Opinion from EU CHMP..
5/29/202012:16EDGARCurrent Report Filing (8-k)
5/28/202018:37BWKEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib)..
5/28/202017:00BWMerck’s KEYTRUDA® (pembrolizumab) Superior to Standard of..
See more news about this stock »
Your Recent History
NYSE
MRK
Merck
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200711 08:08:23